AZEPTIL Solution for injection Ref.[28140] Active ingredients: Tranexamic acid

Source: Υπουργείο Υγείας (CY)  Revision Year: 2016  Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Product name and form

Azeptil 250mg/5ml solution for injection.

Azeptil 500mg/5ml solution for injection.

Pharmaceutical Form

Solution for injection.

A clear colourless solution, pH 6.5 to 8.0.

Qualitative and quantitative composition

Azeptil 250mg/5ml solution for injection: Each ampoule contains 5ml of an aqueous solution containing 250mg tranexamic acid.

Azeptil 500mg/5ml solution for injection: Each ampoule contains 5ml of an aqueous solution containing 500mg tranexamic acid.

Excipients with known effect: sodium methabisulphite.

Each 250mg/5ml ampoule contains 9.15mg sodium methabisulphite.

Each 500mg/5ml ampoule contains 9.15mg sodium methabisulphite

For the full list of excipients, see section 6.1.

Active Ingredient Description
Tranexamic acid

Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid. Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid. Tranexamic acid binds more strongly than aminocaproic acid to both the strong and weak receptor sites of the plasminogen molecule in a ratio corresponding to the difference in potency between the compounds.

List of Excipients

Azeptil 250mg/5ml and 500mg/5ml solution for injection also contain propylene glycol, sodium metabisulfite (E223), sodium hydroxide and water for injection.

Pack sizes and marketing

Azeptil 250mg/5ml and 500mg/5ml solution for injection are filled into brown glass type I ampoules. 5 ampoules are placed into a PVC case. Cases and leaflet in an outer carton. Boxes of ten ampoules are available.

Marketing authorization holder

MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Marketing authorization dates and numbers

Azeptil 250mg/5ml solution for injection: 19835
Azeptil 500mg/5ml solution for injection: 19834

Azeptil 250mg/5ml solution for injection: 19.12.2005/30.05.2012
Azeptil 500mg/5ml solution for injection: 19.12.2005/31.05.2012

Drugs

Drug Countries
AZEPTIL Cyprus, Hong Kong

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.